Gaza Thalassemia Patients Face Life-Threatening Shortages of Blood, Medicine

Thalassemia patients in Gaza hospitals are facing acute shortages of essential medications and blood units, threatening the lives of hundreds of people ^[1].

This crisis underscores the collapse of specialized healthcare in the region, where patients with chronic blood disorders cannot survive without regular transfusions and specific drugs. The lack of supplies transforms a manageable condition into a fatal one.

Medical reports released on Monday indicate that Israeli restrictions on crossings are preventing approximately 70% of necessary medications from entering Gaza [1, 2]. These restrictions have severely depleted hospital stockpiles, leaving medical staff unable to provide the consistent care required for thalassemia treatment.

Compounding the shortage of internal supplies is the inability of patients to seek care outside the territory. The Rafah crossing has remained closed since Feb. 28, 2026 [3, 4].

Because of this closure, thousands of patients are currently waiting for treatment abroad ^[4]. While hundreds are in immediate danger due to the lack of blood and medicine within Gaza's hospitals ^[1], thousands more remain trapped in a system that cannot provide the specialized interventions they need.

Health officials said the combination of blocked imports and restricted movement has created a dual crisis. Patients who require frequent blood transfusions to manage iron overload and anemia are now facing unpredictable availability of blood units ^[1].

Without a diplomatic resolution to open the crossings or a significant increase in medical aid, the mortality rate among those with chronic blood diseases is expected to rise as current reserves are exhausted [1, 2].